Common adverse effects of Wegovy include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (affecting 2050% of users, particularly during dose escalation) Dehydration risk secondary to gastrointestinal effects Dizziness and fatigue especially when combined with caloric restriction Hypoglycaemia primarily a risk when combined with insulin or sulfonylurea therapy
Temporary deferrals are the most common scenario when it comes to medications
If you've recently started semaglutide or are in the dose-adjustment phase, consider waiting until your body has fully adapted to the medication
Donors who were previously deferred due to risk of exposure to CJD / Mad Cow Disease have been reinstated as potential donors
However, each donation requires fresh assessment, as your health status may have changed
Most of the eligibility criteria above are more concerned with your overall blood sugar management and if you're on medications (and what those medications are)